PainReform (PRFX) Short Interest Ratio & Short Volume $5.30 -5.86 (-52.51%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PainReform Short Interest DataPainReform (PRFX) has a short interest of 52,300 shares, representing 9.33% of the float (the number of shares available for trading by the public). This marks a 79.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 832,332 shares to cover all short positions.Current Short Interest52,300 sharesPrevious Short Interest29,100 sharesChange Vs. Previous Month+79.73%Dollar Volume Sold Short$145,394.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares145,000 sharesFloat Size560,300 sharesShort Percent of Float9.33%Today's Trading Volume2,901,318 sharesAverage Trading Volume832,332 sharesToday's Volume Vs. Average349% Short Selling PainReform? Sign up to receive the latest short interest report for PainReform and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRFX Short Interest Over TimePRFX Days to Cover Over TimePRFX Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> PainReform Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202452,300 shares $145,394.00 +79.7%9.3%0 $2.78 11/15/202429,100 shares $61,785.12 -76.0%5.2%0 $2.12 10/31/2024121,100 shares $60,550.00 +98.2%6.2%0.2 $0.50 10/15/202461,100 shares $34,827.00 +6.1%3.1%0.1 $0.57 9/30/202457,600 shares $35,619.84 -11.4%15.4%0.1 $0.62 9/15/202465,000 shares $56,550.00 +2,221.4%17.4%0.2 $0.87 Get the Latest News and Ratings for PRFX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PainReform and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,800 shares $624.40 -96.4%N/A0 $0.22 8/15/202477,000 shares $23,977.80 -14.7%2.6%0.1 $0.31 7/31/202490,300 shares $36,526.35 +75.3%3.3%0.4 $0.40 7/15/202451,500 shares $28,067.50 -1.3%1.9%0.3 $0.55 6/30/202452,200 shares $25,056.00 -56.2%2.7%0.2 $0.48 6/15/2024119,100 shares $61,932.00 +653.8%6.2%0.5 $0.52 5/31/202415,800 shares $11,218.00 -47.2%0.8%0.1 $0.71 5/15/202429,900 shares $23,922.99 +51.0%1.6%0.2 $0.80 4/30/202419,800 shares $18,286.13 -63.7%1.2%0.1 $0.92 4/15/202454,600 shares $53,557.14 +232.9%3.0%0.4 $0.98 3/31/202416,400 shares $29,848.00 +18.0%1.2%0.1 $1.82 3/15/202413,900 shares $25,437.00 +504.4%1.0%0.6 $1.83 2/29/20242,300 shares $4,370.00 -52.1%0.1%0.1 $1.90 2/15/20244,800 shares $10,224.00 +23.1%0.3%0.2 $2.13 1/31/20243,900 shares $7,800.39 -53.6%0.3%0.1 $2.00 1/15/20248,400 shares $20,580.00 No Change0.7%0.3 $2.45 12/31/20238,400 shares $23,100.00 +21.7%0.7%0.3 $2.75 12/15/20236,900 shares $18,078.00 +15.0%0.6%0.4 $2.62 11/30/20236,000 shares $15,000.00 +1,400.0%0.5%0.3 $2.50 11/15/2023400 shares $852.00 -84.0%0.0%0 $2.13 10/31/20232,500 shares $5,450.00 +257.1%0.2%0.1 $2.18 10/15/2023700 shares $1,764.00 +40.0%0.1%0 $2.52 9/30/2023500 shares $1,740.00 -89.8%0.1%0 $3.48 9/15/20234,900 shares $19,061.00 +11.4%0.5%0 $3.89 8/31/20234,400 shares $20,988.00 -59.3%0.4%0 $4.77 8/15/202310,800 shares $62,964.00 -90.2%1.0%0 $5.83 7/31/2023110,400 shares $776,112.00 +106.7%10.4%0.1 $7.03 7/15/202353,400 shares $432,540.00 +820.7%6.3%0 $8.10 6/30/20235,800 shares $31,836.20 -90.9%N/A0 $5.49 6/15/202364,000 shares $31,993.60 -10.4%N/A1.3 $0.50 5/31/202371,400 shares $33,101.04 -8.5%1.2%1.4 $0.46 5/15/202378,000 shares $47,010.60 +16.2%1.3%1.6 $0.60 4/30/202367,100 shares $37,924.92 +3.9%1.1%0.2 $0.57 4/15/202364,600 shares $39,005.48 -4.2%1.1%0.2 $0.60We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol 3/31/202367,400 shares $46,506.00 +28.4%1.2%0.2 $0.69 3/15/202352,500 shares $26,507.25 -53.0%1.0%0.2 $0.50 2/28/2023111,800 shares $69,863.82 -49.7%2.1%0.4 $0.62 2/15/2023222,200 shares $131,764.60 +3,074.3%4.2%0.8 $0.59 1/31/20237,000 shares $3,500.00 +11.1%0.1%0 $0.50 1/15/20236,300 shares $3,150.00 -59.4%0.1%0.4 $0.50 12/30/202215,500 shares $6,396.85 -29.2%0.3%1 $0.41 12/15/202221,900 shares $9,756.45 +2,637.5%0.4%1.4 $0.45 11/30/2022800 shares $356.04 +100.0%0.0%0.1 $0.45 11/15/2022400 shares $220.04 -87.9%0.0%0 $0.55 10/31/20223,300 shares $1,980.00 -66.0%0.1%0.4 $0.60 10/15/20229,700 shares $6,330.22 +79.6%0.2%0.7 $0.65 9/30/20225,400 shares $3,726.00 -32.5%0.1%0.3 $0.69 9/15/20228,000 shares $5,841.21 -13.0%0.1%0.4 $0.73 8/31/20229,200 shares $6,116.16 -56.8%0.2%0.4 $0.66 8/15/202221,300 shares $17,572.50 +49.0%0.4%0.8 $0.83 7/31/202214,300 shares $10,153.00 +98.6%0.3%0.5 $0.71 7/15/20227,200 shares $5,760.00 +1,100.0%0.1%0.3 $0.80 6/30/2022600 shares $568.80 -88.9%0.0%0 $0.95 6/15/20225,400 shares $5,562.00 -14.3%0.1%0.2 $1.03 5/31/20226,300 shares $5,668.73 -77.7%0.1%0.1 $0.90 5/15/202228,200 shares $22,080.60 +104.4%0.5%0.3 $0.78 4/30/202213,800 shares $12,958.20 -53.4%0.3%0.2 $0.94 4/15/202229,600 shares $35,520.00 -38.3%0.6%0.3 $1.20 3/31/202248,000 shares $59,520.00 -36.6%0.9%0.4 $1.24 3/15/202275,700 shares $84,027.00 -13.9%1.5%0.5 $1.11 2/28/202287,900 shares $88,779.00 +4.8%1.7%0.7 $1.01 2/15/202283,900 shares $95,646.00 -35.9%1.6%0.5 $1.14 1/31/2022130,800 shares $143,893.08 +35.0%2.5%0.3 $1.10 1/15/202296,900 shares $134,691.00 +78.5%2.0%0.2 $1.39 12/31/202154,300 shares $72,219.00 -50.4%1.1%0.1 $1.33 12/15/2021109,400 shares $170,664.00 -62.7%2.3%0.2 $1.56 11/30/2021293,000 shares $524,470.00 +293.8%6.0%0.6 $1.79 11/15/202174,400 shares $188,976.00 +98.4%1.5%0.1 $2.54 10/29/202137,500 shares $88,125.00 -31.7%0.8%0.1 $2.35 10/15/202154,900 shares $145,485.00 +193.6%1.2%0.1 $2.65 9/30/202118,700 shares $51,799.00 -92.1%0.4%0 $2.77 9/15/2021236,800 shares $680,800.00 -43.4%5.3%0.1 $2.88 8/31/2021418,300 shares $1.23 million -14.9%9.4%0.3 $2.95 8/13/2021491,700 shares $1.33 million +24.3%11.1%0.3 $2.71 7/30/2021395,600 shares $1.14 million +306.6%8.9%0.3 $2.88 7/15/202197,300 shares $295,558.48 +40.0%2.2%0.1 $3.04 6/30/202169,500 shares $195,990.00 +2.7%1.6%0.3 $2.82 6/15/202167,700 shares $190,237.00 -1.7%1.5%0.3 $2.81 5/28/202168,900 shares $206,700.00 -13.2%1.6%0.3 $3.00 5/14/202179,400 shares $195,324.00 -20.2%1.8%0.4 $2.46 4/30/202199,500 shares $340,290.00 -12.4%2.2%0.4 $3.42 4/15/2021113,600 shares $415,776.00 +59.3%2.6%0.5 $3.66 3/31/202171,300 shares $309,442.00 +90.6%2.0%0.4 $4.34 3/15/202137,400 shares $200,464.00 -66.4%1.2%0.2 $5.36Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 2/26/2021111,400 shares $701,820.00 +300.7%3.6%0.4 $6.30 2/12/202127,800 shares $150,398.00 +219.5%0.9%0.1 $5.41 1/29/20218,700 shares $37,932.00 +155.9%0.3%0 $4.36 1/15/20213,400 shares $14,960.00 No Change0.1%0 $4.40 PRFX Short Interest - Frequently Asked Questions What is PainReform's current short interest? Short interest is the volume of PainReform shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 52,300 shares of PRFX short. 9.33% of PainReform's shares are currently sold short. Learn More on PainReform's current short interest. What is a good short interest percentage for PainReform? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.33% of PainReform's floating shares are currently sold short. Is PainReform's short interest increasing or decreasing? PainReform saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 52,300 shares, an increase of 79.7% from the previous total of 29,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PainReform's float size? PainReform currently has issued a total of 145,000 shares. Some of PainReform's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PainReform currently has a public float of 560,300 shares. How does PainReform's short interest compare to its competitors? 9.33% of PainReform's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PainReform: Psyence Biomedical Ltd. (1.66%), Oncternal Therapeutics, Inc. (0.54%), Eterna Therapeutics Inc. (0.24%), Revelation Biosciences, Inc. (1.95%), China SXT Pharmaceuticals, Inc. (2.10%), Altamira Therapeutics Ltd. (1.35%), Trevena, Inc. (8.55%), Sonnet BioTherapeutics Holdings, Inc. (5.06%), ASLAN Pharmaceuticals Limited (1.40%), Biodexa Pharmaceuticals Plc (43.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short PainReform stock? Short selling PRFX is an investing strategy that aims to generate trading profit from PainReform as its price is falling. PRFX shares are trading down $5.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PainReform? A short squeeze for PainReform occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRFX, which in turn drives the price of the stock up even further. How often is PainReform's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRFX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies PBM Short Interest ONCT Short Interest ERNA Short Interest REVB Short Interest SXTC Short Interest CYTO Short Interest TRVN Short Interest SONN Short Interest ASLN Short Interest BDRX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRFX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainReform Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PainReform With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRFX Stock Alerts